Kevin P Weinfurt1, James W Griffith2, Kathryn E Flynn3, David Cella2, Tamara Bavendam4, Jonathan B Wiseman5, Victor P Andreev5, H Henry Lai6, Alice B Liu7, Ziya Kirkali4, Anne P Cameron8, Catherine S Bradley9. 1. Duke University Medical Center , Durham , North Carolina. 2. Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University , Chicago , Illinois. 3. Medical College of Wisconsin , Milwaukee , Wisconsin. 4. National Institute of Diabetes and Digestive and Kidney Diseases , Bethesda , Maryland. 5. Arbor Research Collaborative for Health , Ann Arbor , Michigan. 6. Washington University School of Medicine , St. Louis , Missouri. 7. University of Washington , Seattle , Washington. 8. University of Michigan , Ann Arbor , Michigan. 9. Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa , Iowa City , Iowa.
Abstract
PURPOSE: To improve the potential for finding clinically important subtypes of patients with lower urinary tract symptoms we developed the CASUS (Comprehensive Assessment of Self-reported Urinary Symptoms). We used it to present data on the experiences of lower urinary tract symptoms in treatment seeking women and men from a prospective observational cohort. MATERIALS AND METHODS: We created an initial list of lower urinary tract symptoms that were confirmed in 22 qualitative interviews with providers, and 88 qualitative interviews with care seeking and noncare seeking women and men with lower urinary tract symptoms. Items from extant measures were adopted and revised, and new items were developed. All items were evaluated for understanding in 64 cognitive interviews. Items were administered to a prospective cohort of female and male patients with lower urinary tract symptoms who were seeking care. Analyses were done to describe item response distributions and correlations among item responses separately for women and men. RESULTS: A total of 444 males and 372 females provided responses to the CASUS. Several sets of items showed different relationships for women compared to men. In particular the associations between sensation related items and incontinence related items were generally positive among females but often negative among males. CONCLUSIONS: After using an intensive development process the CASUS addresses a wide range of lower urinary tract symptoms. It should help identify clinically important subtypes of patients. Further, item collection can provide the foundation for shorter measures for use in the clinic and as trial end points.
PURPOSE: To improve the potential for finding clinically important subtypes of patients with lower urinary tract symptoms we developed the CASUS (Comprehensive Assessment of Self-reported Urinary Symptoms). We used it to present data on the experiences of lower urinary tract symptoms in treatment seeking women and men from a prospective observational cohort. MATERIALS AND METHODS: We created an initial list of lower urinary tract symptoms that were confirmed in 22 qualitative interviews with providers, and 88 qualitative interviews with care seeking and noncare seeking women and men with lower urinary tract symptoms. Items from extant measures were adopted and revised, and new items were developed. All items were evaluated for understanding in 64 cognitive interviews. Items were administered to a prospective cohort of female and male patients with lower urinary tract symptoms who were seeking care. Analyses were done to describe item response distributions and correlations among item responses separately for women and men. RESULTS: A total of 444 males and 372 females provided responses to the CASUS. Several sets of items showed different relationships for women compared to men. In particular the associations between sensation related items and incontinence related items were generally positive among females but often negative among males. CONCLUSIONS: After using an intensive development process the CASUS addresses a wide range of lower urinary tract symptoms. It should help identify clinically important subtypes of patients. Further, item collection can provide the foundation for shorter measures for use in the clinic and as trial end points.
Entities:
Keywords:
lower urinary tract symptoms; patient acceptance of health care; patient reported outcome measures; surveys and questionnaires; urinary bladder
Authors: James W Griffith; Emily E Messersmith; Brenda W Gillespie; Jonathan B Wiseman; Kathryn E Flynn; Ziya Kirkali; John W Kusek; Tamara Bavendam; David Cella; Karl J Kreder; Jasmine J Nero; Maria E Corona; Catherine S Bradley; Kimberly S Kenton; Brian T Helfand; Robert M Merion; Kevin P Weinfurt Journal: J Urol Date: 2017-07-20 Impact factor: 7.450
Authors: Karin S Coyne; Alexandra I Barsdorf; Christine Thompson; Andrea Ireland; Ian Milsom; Chris Chapple; Zoe S Kopp; Tamara Bavendam Journal: Neurourol Urodyn Date: 2012-03-06 Impact factor: 2.696
Authors: Anne P Cameron; Christina Lewicky-Gaupp; Abigail R Smith; Brian T Helfand; John L Gore; J Quentin Clemens; Claire C Yang; Nazema Y Siddiqui; H Henry Lai; James W Griffith; Victor P Andreev; Gang Liu; Kevin Weinfurt; Cindy L Amundsen; Catherine S Bradley; John W Kusek; Ziya Kirkali Journal: J Urol Date: 2017-10-28 Impact factor: 7.450
Authors: Vivian W Sung; James W Griffith; Rebecca G Rogers; Christina A Raker; Melissa A Clark Journal: Qual Life Res Date: 2016-01-06 Impact factor: 4.147
Authors: Brian T Helfand; Abigail R Smith; H Henry Lai; Claire C Yang; John L Gore; Brad A Erickson; Karl J Kreder; Anne P Cameron; Kevin P Weinfurt; James W Griffith; Aaron Lentz; Pooja Talaty; Victor P Andreev; Ziya Kirkali Journal: J Urol Date: 2018-03-01 Impact factor: 7.450
Authors: David Cella; Abigail R Smith; James W Griffith; Kathryn E Flynn; Catherine S Bradley; Brenda W Gillespie; Ziya Kirkali; Pooja Talaty; J Eric Jelovsek; Brian T Helfand; Kevin P Weinfurt Journal: Neurourol Urodyn Date: 2019-06-21 Impact factor: 2.696
Authors: David Cella; Abigail R Smith; James W Griffith; Ziya Kirkali; Kathryn E Flynn; Catherine S Bradley; J Eric Jelovsek; Brenda W Gillespie; Brian T Helfand; Pooja Talaty; Kevin P Weinfurt Journal: J Urol Date: 2019-07-31 Impact factor: 7.450
Authors: Kathryn E Flynn; Sarah A Mansfield; Abigail R Smith; Brenda W Gillespie; Catherine S Bradley; David Cella; J Quentin Clemens; Margaret E Helmuth; H Henry Lai; Ziya Kirkali; Pooja Talaty; Kevin P Weinfurt Journal: J Urol Date: 2019-09-06 Impact factor: 7.450
Authors: Kathryn E Flynn; Sarah A Mansfield; Abigail R Smith; Brenda W Gillespie; Catherine S Bradley; David Cella; Margaret E Helmuth; H Henry Lai; Ziya Kirkali; Pooja Talaty; James W Griffith; Kevin P Weinfurt Journal: Neurourol Urodyn Date: 2020-07-23 Impact factor: 2.696
Authors: Benjamin N Breyer; Scott R Bauer; Austin W Lee; Stacey A Kenfield; Elizabeth Y Wang; Anthony Enriquez; Akinyemi Oni-Orisan; Michael A Steinman; Ida Sim Journal: JMIR Form Res Date: 2021-12-10
Authors: Charles D Scales; Alana C Desai; Jonathan D Harper; H Henry Lai; Naim M Maalouf; Peter P Reese; Gregory E Tasian; Hussein R Al-Khalidi; Ziya Kirkali; Hunter Wessells Journal: Am J Kidney Dis Date: 2020-11-16 Impact factor: 11.072